• New device uses light to screen for melanoma

    by  • 10 November 2011 • General News

    Dr. Joseph Gulfo, CEO of Mela Sciences, works with the company's MelaFind medical device. The Food and Drug Administration on Wednesday approved the device, which makes detailed, digital images of skin growths and uses a computer to analyze them for signs of cancer, offering a sort of second opinion to doctors.Dermatologists will soon get some high-tech help deciding which suspicious-looking moles should be removed and checked for melanoma, the deadliest form of skin cancer.


    About

    After thirty years in the investment and public relations field, we have switched our focus lobbing between American and European companies facilitating business and licensing opportunities . Starting in the year 2003 L.G.Zangani, LLC has organized the annual event "Pharmafinance" in Milano and Roma. Pharmafinance is unique in its structure and has the ability to expose opportunities generated offering licensing or developing opportunities. Recently we have started the site www.letcombatpain.com creating the first worldwide site for pain news. The site also offers an humanitarian tools where individuals or professionals confronted by unique and rare forms of pain can communicate with all the members of the group simply sending oneemail. This ability of having a mass communication tool can also be used to expose innovative pain products or ideas. Additionally has also been invited as speaker to several conferences in Europe to discuss the uniqueness and functionality of his site .

    http://www.zangani.com